Models of Phase 1 vaccine trials: optimization of trial design to minimize risks of multiple serious adverse events Fulltext Access 8 Pages 2005
Vaccination against foot and mouth disease reduces virus transmission in groups of calves Fulltext Access 8 Pages 2005
CD4+ T cell epitope affinity to MHC II influences the magnitude of CTL responses elicited by DNA epitope vaccines Fulltext Access 8 Pages 2005
Role of IgA in the defense against respiratory infections: IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG Fulltext Access 8 Pages 2005
Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c—a member of the esat-6 gene family Fulltext Access 8 Pages 2005
Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice Fulltext Access 8 Pages 2005
Modified anthrax fusion proteins deliver HIV antigens through MHC Class I and II pathways Fulltext Access 8 Pages 2005
Influence of glycosylphosphatidylinositol anchorage on the efficacy of DNA vaccines encoding Plasmodium yoelii merozoite surface protein 4/5 Fulltext Access 8 Pages 2005
Improvement of collagen-induced arthritis by active immunization against murine IL-1β peptides designed by molecular modelling Fulltext Access 8 Pages 2005
Systemic mobilization of antigen presenting cells, with a chimeric Flt-3 and G-CSF receptor agonist, during immunization of Macaca mulatta with HIV-1 antigens is insufficient to modulate immune responses or vaccine efficacy Fulltext Access 8 Pages 2005
A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant Fulltext Access 8 Pages 2005
Immunodominance of low molecular weight secretory polypeptides of Mycobacterium tuberculosis to induce cytotoxic T-lymphocyte response Fulltext Access 8 Pages 2005
Associations of daycare and school entry vaccination requirements with varicella immunization rates Fulltext Access 8 Pages 2005
Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein Fulltext Access 8 Pages 2005
Passive immunization of immune-suppressed animals: Chicken antibodies protect against Ornithobacterium rhinotracheale infection Fulltext Access 8 Pages 2005
Protection of cultured Cyprinus carpio against a lethal viral disease by an attenuated virus vaccine Fulltext Access 8 Pages 2005
Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens Fulltext Access 8 Pages 2005
Identification and characterization of HIV-1-specific CD8+ T cell epitopes presented by HLA-A*2601 Fulltext Access 8 Pages 2005
Immunization with pseudorabies virus harboring Fc domain of IgG makes a contribution to protection of mice from lethal challenge Fulltext Access 8 Pages 2005
Haemolytic activities and adjuvant effect of Astragalus membranaceus saponins (AMS) on the immune responses to ovalbumin in mice Fulltext Access 8 Pages 2005
Peptide mimics as surrogate immunogens of mosquito midgut carbohydrate malaria transmission blocking targets Fulltext Access 8 Pages 2005
Serological and epidemiological effects and influence factors of primary immunization with current live attenuated measles vaccine (Hu191) among infants aged 6–15 months Fulltext Access 8 Pages 2005
Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research Fulltext Access 8 Pages 2005
Malaria vaccines: using models of immunity and functional genomics tools to accelerate the development of vaccines against Plasmodium falciparum Fulltext Access 8 Pages 2005
Plasmid vaccination of stable HIV-positive subjects on antiviral treatment results in enhanced CD8 T-cell immunity and increased control of viral “blips” Fulltext Access 8 Pages 2005
Site-specific peptide vaccines for immunotherapy and immunization against chronic diseases, cancer, infectious diseases, and for veterinary applications Fulltext Access 8 Pages 2005
Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys Fulltext Access 8 Pages 2005
Induction of Gag-specific T-cell responses by therapeutic immunization with a Gag-expressing Sendai virus vector in macaques chronically infected with simian-human immunodeficiency virus Fulltext Access 8 Pages 2005
Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria Fulltext Access 8 Pages 2005
Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylanicum Fulltext Access 8 Pages 2005
Systemic immunization with streptococcal immunoglobulin-binding protein Sib35 induces protective immunity against group A Streptococcus challenge in mice Fulltext Access 8 Pages 2005
Mucosal targeting of allergen-loaded microspheres by Aleuria aurantia lectin Fulltext Access 8 Pages 2005
Neutralising antibodies against the transmembrane protein of feline leukaemia virus (FeLV) Fulltext Access 8 Pages 2005
CpG oligonucleotides induce strong humoral but only weak CD4+ T cell responses to protein antigens in rhesus macaques in vivo Fulltext Access 8 Pages 2005
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice Fulltext Access 8 Pages 2005
Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age Fulltext Access 8 Pages 2005
Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes Fulltext Access 8 Pages 2005
Yellow fever vaccine: An updated assessment of advanced age as a risk factor for serious adverse events Fulltext Access 8 Pages 2005
The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus Fulltext Access 8 Pages 2005
Comparative efficacy of replicating smallpox vaccine strains in a Murine Challenge Model Fulltext Access 8 Pages 2005
Aluminium phosphate potentiates the efficacy of DNA vaccines against Leishmaniamexicana Fulltext Access 8 Pages 2005
Live attenuated bluetongue vaccine viruses in Dorset Poll sheep, before and after passage in vector midges (Diptera: Ceratopogonidae) Fulltext Access 8 Pages 2005
Costs of running a universal adolescent hepatitis B vaccination programme Fulltext Access 8 Pages 2005
Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs Fulltext Access 8 Pages 2005
Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs Fulltext Access 8 Pages 2005
Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000–2002 Fulltext Access 8 Pages 2005
All-trans retinoic acid biases immune response induced by DNA vaccine in a Th2 direction Fulltext Access 8 Pages 2005
Effect of adjuvant on reactogenicity and long-term immunogenicity of the malaria Vaccine ICC-1132 in macaques Fulltext Access 9 Pages 2005
Heat-shock protein 70 acts as an effective adjuvant in neonatal mice and confers protection against challenge with Herpes Simplex Virus Fulltext Access 9 Pages 2005
The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response Fulltext Access 9 Pages 2005
Uptake of varicella vaccine—a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation Fulltext Access 9 Pages 2005
Potential for broad-spectrum protection against feline calicivirus using an attenuated myxoma virus expressing a chimeric FCV capsid protein Fulltext Access 9 Pages 2005
Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins Fulltext Access 9 Pages 2005
Hepatitis A virus infection in the United States: Serologic results from the Third National Health and Nutrition Examination Survey Fulltext Access 9 Pages 2005
Immunopotentiation of the antibody response against influenza HA with apoptotic bodies generated by rabies virus G-ERA protein-driven apoptosis Fulltext Access 9 Pages 2005
Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetellapertussis variant isolates in a mouse model Fulltext Access 9 Pages 2005
Co-immunization of BALB/c mice with recombinant immunogens containing G protein fragment and chimeric CTL epitope of respiratory syncytial virus induces enhanced cellular immunity and high level of antibody response Fulltext Access 9 Pages 2005
The immune response of the Chacma baboon to Bacille Calmette Guerin: development of a primate model for BCG-based vaccine research Fulltext Access 9 Pages 2005
Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice Fulltext Access 9 Pages 2005
Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit coaggregation by P. gingivalis Fulltext Access 9 Pages 2005
Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an αβ T cell- and interferon gamma- dependent mech Fulltext Access 9 Pages 2005
Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli Fulltext Access 9 Pages 2005
A mimotope peptide-based anti-cancer vaccine selected by BAT monoclonal antibody Fulltext Access 9 Pages 2005
CpG motif in ATCGAT hexamer improves DNA-vaccine efficiency against lethal Pseudorabies virus infection in pigs Fulltext Access 9 Pages 2005
Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency Fulltext Access 9 Pages 2005
Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants Fulltext Access 9 Pages 2005
Prime-boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1 Fulltext Access 9 Pages 2005
Enhancement of humoral and cellular immune responses by an oral Salmonella choleraesuis vaccine expressing porcine prothymosin α Fulltext Access 9 Pages 2005
Oral immunization with a shiga toxin B subunit::rotavirus NSP490 fusion protein protects mice against gastroenteritis Fulltext Access 9 Pages 2005
New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development Fulltext Access 9 Pages 2005
Porcine rotavirus strain Gottfried-based human rotavirus candidate vaccines: Construction and characterization Fulltext Access 9 Pages 2005
Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41 Fulltext Access 9 Pages 2005
Combined DNA vaccines formulated either in DDA or in saline protect cattle from Mycobacterium bovis infection Fulltext Access 9 Pages 2005
Influenza vaccination coverage rates in five European countries—a population-based cross-sectional analysis of two consecutive influenza seasons Fulltext Access 9 Pages 2005
Immunologic responses and adverse reactions to Freund's-adjuvanted porcine zona pellucida immunocontraceptives in domestic cats Fulltext Access 9 Pages 2005
Tissue distribution of a plasmid DNA containing epitopes of foot-and-mouth disease virus in mice Fulltext Access 9 Pages 2005
Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins Fulltext Access 9 Pages 2005
Identification of dominant epitopes of synthetic immunocontraceptive vaccines that induce antibodies in dogs Fulltext Access 9 Pages 2005
Financial requirements of immunisation programmes in developing countries: a 2004–2014 perspective Fulltext Access 9 Pages 2005
Salmonella typhimurium grown in iron-rich media, inactivated with ferric chloride and adjuvanted with homologous bacterial DNA is potent and efficacious vaccine in mice Fulltext Access 9 Pages 2005
Rationale and design of the prevention of respiratory infections and management in children (PRIMAKid) study: A randomized controlled trial on the effectiveness and costs of combined influenza and pneumococcal vaccination in pre-school children with recur Fulltext Access 9 Pages 2005
Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children Fulltext Access 9 Pages 2005
Immunoprophylaxis with DNA vaccination inhibits Th2-mediated responses and airway inflammation in mice sensitised with the major timothy grass pollen allergen Phl p 5b Fulltext Access 9 Pages 2005
Comparative pre-clinical and clinical experience with oral polio vaccine produced on MRC-5 cells or on primary monkey kidney cells Fulltext Access 9 Pages 2005
A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates Fulltext Access 9 Pages 2005
Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses Fulltext Access 9 Pages 2005
Prevention of perinatal transmission of hepatitis B to babies at high risk: an evaluation Fulltext Access 9 Pages 2005
Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice Fulltext Access 9 Pages 2005
Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants Fulltext Access 9 Pages 2005
Investigation of nontypeable Haemophilus influenzae outer membrane protein P6 as a new carrier for lipooligosaccharide conjugate vaccines Fulltext Access 9 Pages 2005
Oral administration of second-generation immunomodulatory oligonucleotides induces mucosal Th1 immune responses and adjuvant activity Fulltext Access 9 Pages 2005
Characterisation of the antibody response to a totally synthetic immunocontraceptive peptide vaccine based on LHRH Fulltext Access 9 Pages 2005